Reviva Pharmaceuticals Holdings Stock Analysis
| RVPHW Stock | USD 0.13 0.02 13.33% |
Reviva Pharmaceuticals Holdings is overvalued with Real Value of 0.12 and Hype Value of 0.13. The main objective of Reviva Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Reviva Pharmaceuticals Holdings is worth, separate from its market price. There are two main types of Reviva Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Reviva Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Reviva Pharmaceuticals is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Reviva Stock trading window is adjusted to America/New York timezone.
Reviva |
Reviva Stock Analysis Notes
The company had not issued any dividends in recent years. Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. Reviva Pharmaceuticals is traded on NASDAQ Exchange in the United States. To find out more about Reviva Pharmaceuticals Holdings contact Laxminarayan Bhat at 408 501 8881 or learn more at https://www.revivapharma.com.Reviva Pharmaceuticals Investment Alerts
| Reviva Pharmaceuticals is way too risky over 90 days horizon | |
| Reviva Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Reviva Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Reviva Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Reviva Pharmaceuticals Holdings has accumulated 17.98 M in total debt. Reviva Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Reviva Pharmaceuticals' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (39.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Reviva Pharmaceuticals Holdings has accumulated about 353.26 K in cash with (28.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Reviva Pharmaceuticals has a poor financial position based on the latest SEC disclosures |
Reviva Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.81 M.Technical Drivers
As of the 17th of February 2025, Reviva Pharmaceuticals holds the Coefficient Of Variation of 1423.8, risk adjusted performance of 0.0594, and Semi Deviation of 14.95. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Reviva Pharmaceuticals, as well as the relationship between them. Please check Reviva Pharmaceuticals standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Reviva Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 0.13 per share. As Reviva Pharmaceuticals appears to be a penny stock we also advise to check out its total risk alpha numbers.Reviva Pharmaceuticals Price Movement Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Reviva Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Reviva Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Reviva Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Reviva Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Reviva Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Reviva Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Patel Purav over two months ago Discretionary transaction by Patel Purav of tradable shares of Reviva Pharmaceuticals subject to Rule 16b-3 | ||
Laxminarayan Bhat over six months ago Acquisition by Laxminarayan Bhat of 443000 shares of Reviva Pharmaceuticals at 6.74 subject to Rule 16b-3 | ||
Saxena Parag over six months ago Acquisition by Saxena Parag of 4000 shares of Reviva Pharmaceuticals at 4.73 subject to Rule 16b-3 |
Reviva Pharmaceuticals Predictive Daily Indicators
Reviva Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Reviva Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Reviva Pharmaceuticals Forecast Models
Reviva Pharmaceuticals' time-series forecasting models are one of many Reviva Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Reviva Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Reviva Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Reviva Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Reviva shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Reviva Pharmaceuticals. By using and applying Reviva Stock analysis, traders can create a robust methodology for identifying Reviva entry and exit points for their positions.
Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. Reviva Pharmaceuticals is traded on NASDAQ Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Reviva Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Additional Tools for Reviva Stock Analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.